These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26936531)

  • 1. Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma.
    Honjo H; Kaira K; Miyazaki T; Yokobori T; Kanai Y; Nagamori S; Oyama T; Asao T; Kuwano H
    J Surg Oncol; 2016 Mar; 113(4):381-9. PubMed ID: 26936531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
    Toyoda M; Kaira K; Ohshima Y; Ishioka NS; Shino M; Sakakura K; Takayasu Y; Takahashi K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Br J Cancer; 2014 May; 110(10):2506-13. PubMed ID: 24762957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
    Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.
    Kaira K; Sunose Y; Arakawa K; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
    Histopathology; 2015 Jan; 66(2):234-43. PubMed ID: 24845232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
    Namikawa M; Kakizaki S; Kaira K; Tojima H; Yamazaki Y; Horiguchi N; Sato K; Oriuchi N; Tominaga H; Sunose Y; Nagamori S; Kanai Y; Oyama T; Takeyoshi I; Yamada M
    Hepatol Res; 2015 Sep; 45(9):1014-1022. PubMed ID: 25297701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
    Kobayashi H; Ishii Y; Takayama T
    J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.
    Kaira K; Nakamura K; Hirakawa T; Imai H; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Tsukamoto N; Oyama T; Asao T; Minegishi T
    Am J Transl Res; 2015; 7(6):1161-71. PubMed ID: 26279759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
    Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.
    Yazawa T; Shimizu K; Kaira K; Nagashima T; Ohtaki Y; Atsumi J; Obayashi K; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
    Am J Transl Res; 2015; 7(6):1126-39. PubMed ID: 26279756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
    Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
    Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glutamine transport to suppress melanoma cell growth.
    Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
    Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.
    Shimizu K; Kaira K; Tomizawa Y; Sunaga N; Kawashima O; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yamada M; Oyama T; Takeyoshi I
    Br J Cancer; 2014 Apr; 110(8):2030-9. PubMed ID: 24603303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma.
    Witte D; Ali N; Carlson N; Younes M
    Anticancer Res; 2002; 22(5):2555-7. PubMed ID: 12529963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.